Your browser doesn't support javascript.
loading
Design, synthesis, and biological evaluation of ligustrazine/resveratrol hybrids as potential anti-ischemic stroke agents.
Zhang, Yin-Qiu; Wu, Jian-Bing; Yin, Wei; Zhang, Yi-Hua; Huang, Zhang-Jian.
Affiliation
  • Zhang YQ; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China.
  • Wu JB; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China.
  • Yin W; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China.
  • Zhang YH; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China. Electronic address: zyhtgd@163.com.
  • Huang ZJ; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China. Electronic address: zhangjianhuang@cpu.edu.cn.
Chin J Nat Med ; 18(8): 633-640, 2020 Aug.
Article in En | MEDLINE | ID: mdl-32768171

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Brain Ischemia / Platelet Aggregation / Neuroprotective Agents / Resveratrol / Antioxidants Language: En Journal: Chin J Nat Med Year: 2020 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Brain Ischemia / Platelet Aggregation / Neuroprotective Agents / Resveratrol / Antioxidants Language: En Journal: Chin J Nat Med Year: 2020 Type: Article Affiliation country: China